Future atherosclerotic cardiovascular disease in systemic lupus erythematosus based on CSTAR (XXVIII): the effect of different antiphospholipid antibodies isotypes

Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT. Update omicronn the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis. 2021;80(1):14–25.

Article  PubMed  Google Scholar 

Chambers SA, Allen E, Rahman A, Isenberg D. Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years. Rheumatology (Oxford). 2009;48(6):673–5.

Article  PubMed  Google Scholar 

Urowitz MB, Gladman DD, Ibanez D, Fortin PR, Bae SC, Gordon C, et al. Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort. Arthritis Care Res (Hoboken). 2012;64(1):132–7.

Article  PubMed  Google Scholar 

de Lemos JA, Ayers CR, Levine BD, deFilippi CR, Wang TJ, Hundley WG, et al. Multimodality strategy for cardiovascular risk assessment: performance in 2 population-based cohorts. Circulation. 2017;135(22):2119–32.

Article  PubMed  PubMed Central  Google Scholar 

Conrad N, Verbeke G, Molenberghs G, Goetschalckx L, Callender T, Cambridge G, et al. Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet. 2022;400(10354):733–43.

Article  PubMed  Google Scholar 

Taraborelli M, Leuenberger L, Lazzaroni MG, Martinazzi N, Zhang W, Franceschini F, et al. The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus. Lupus. 2016;25(12):1365–8.

Article  PubMed  Google Scholar 

Knight JS, Kanthi Y. Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome. Semin Immunopathol. 2022;44(3):347–62.

Article  PubMed  PubMed Central  Google Scholar 

Kolitz T, Shiber S, Sharabi I, Winder A, Zandman-Goddard G. Cardiac manifestations of antiphospholipid syndrome with focus on its primary form. Front Immunol. 2019;10:941.

Article  PubMed  PubMed Central  Google Scholar 

Li M, Wang Y, Zhao J, Wang Q, Wang Z, Tian X, et al. Chinese SLE Treatment and Research Group (CSTAR) registry 2009–2019: major clinical characteristics of Chinese patients with systemic lupus erythematosus. Rheumatol Immunol Res. 2021;2(1):43–7.

Article  PubMed  PubMed Central  Google Scholar 

Huang C, Zhao J, Tian X, Wang Q, Xu D, Li M, et al. RheumCloud App: a novel mobile application for the management of rheumatic diseases patients in China. Rheumatol Immunol Res. 2022;3(4):184–9.

Article  PubMed  PubMed Central  Google Scholar 

Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.

Article  PubMed  Google Scholar 

Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–86.

Article  PubMed  PubMed Central  Google Scholar 

Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151–9.

Article  PubMed  Google Scholar 

Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken). 2012;64(6):797–808.

Article  PubMed  Google Scholar 

Devreese KMJ, de Groot PG, de Laat B, Erkan D, Favaloro EJ, Mackie I, et al. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation. J Thromb Haemost. 2020;18(11):2828–39.

Article  PubMed  Google Scholar 

Hu C, Li S, Xie Z, You H, Jiang H, Shi Y, et al. Comparison of different test systems for the detection of antiphospholipid antibodies in a Chinese cohort. Front Immunol. 2021;12:648881.

Article  PubMed  PubMed Central  Google Scholar 

Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.

Article  PubMed  Google Scholar 

Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019;78(10):1296–304.

Article  PubMed  Google Scholar 

Sciascia S, Sanna G, Murru V, Roccatello D, Khamashta MA, Bertolaccini ML. GAPSS: the global anti-phospholipid syndrome score. Rheumatology (Oxford). 2013;52(8):1397–403.

Article  PubMed  Google Scholar 

Bruce IN, O’Keeffe AG, Farewell V, Hanly JG, Manzi S, Su L, et al. Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. Ann Rheum Dis. 2015;74(9):1706–13.

Article  PubMed  Google Scholar 

Taraborelli M, Cavazzana I, Martinazzi N, Lazzaroni MG, Fredi M, Andreoli L, et al. Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years. Lupus. 2017;26(11):1197–204.

Article  PubMed  Google Scholar 

Segura BT, Bernstein BS, McDonnell T, Wincup C, V MR, Giles I, et al. Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort. Rheumatology (Oxford). 2020;59(3):698.

Mikdashi J, Handwerger B. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Rheumatology (Oxford). 2004;43(12):1555–60.

Article  PubMed  Google Scholar 

Pinto-Peñaranda LF, Muñoz-Grajales C, Echeverri Garcia AF, Velásquez-Franco CJ, Mesa-Navas MA, Zuluaga Quintero M, et al. Antiphospholipid antibodies, steroid dose, arterial hypertension, relapses, and late-onset predict organ damage in a population of Colombian patients with systemic lupus erythematosus. Clin Rheumatol. 2018;37(4):949–54.

Article  PubMed  Google Scholar 

Katz G, Smilowitz NR, Blazer A, Clancy R, Buyon JP, Berger JS. Systemic lupus erythematosus and increased prevalence of atherosclerotic cardiovascular disease in hospitalized patients. Mayo Clin Proc. 2019;94(8):143C6–1443.

Article  Google Scholar 

Lu X, Wang Y, Zhang J, Pu D, Hu N, Luo J, et al. Patients with systemic lupus erythematosus face a high risk of cardiovascular disease: a systematic review and Meta-analysis. Int Immunopharmacol. 2021;94:107466.

Article  PubMed  Google Scholar 

Blachut D, Przywara-Chowaniec B, Tomasik A, Kukulski T, Morawiec B. Update of potential biomarkers in risk prediction and monitoring of atherosclerosis in systemic lupus erythematosus to prevent cardiovascular disease. Biomedicines. 2023;11(10):2814. https://doi.org/10.3390/biomedicines11102814.

McMahon M, Skaggs B. Pathogenesis and treatment of atherosclerosis in lupus. Rheum Dis Clin North Am. 2014;40(3):475–95 viii.

Article  PubMed  PubMed Central  Google Scholar 

Zuo Y, Navaz S, Liang W, Li C, Ayers CR, Rysenga CE, et al. Prevalence of antiphospholipid antibodies and association with incident cardiovascular events. JAMA Netw Open. 2023;6(4):e236530.

Article  PubMed  PubMed Central  Google Scholar 

Conti F, Ceccarelli F, Perricone C, Leccese I, Massaro L, Pacucci VA, et al. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort. Lupus. 2016;25(7):719–26.

Article  PubMed  Google Scholar 

Ünlü O, Zuily S, Erkan D. The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus. Eur J Rheumatol. 2016;3(2):75–84.

Article  PubMed  Google Scholar 

Ceccarelli F, Perricone C, Natalucci F, Picciariello L, Olivieri G, Cafaro G, et al. Organ damage in systemic lupus erythematosus patients: a multifactorial phenomenon. Autoimmun Rev. 2023;22(8):103374.

Article  PubMed  Google Scholar 

Corban MT, Duarte-Garcia A, McBane RD, Matteson EL, Lerman LO, Lerman A. Antiphospholipid syndrome: role of vascular endothelial cells and implications for risk stratification and targeted therapeutics. J Am Coll Cardiol. 2017;69(18):2317–30.

Article  PubMed  Google Scholar 

Urbanus RT, Siegerink B, Roest M, Rosendaal FR, de Groot PG, Algra A. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol. 2009;8(11):998–1005.

Article  PubMed 

留言 (0)

沒有登入
gif